However, this biomarker has limited utility, as some patients with high PD‐L1 expression experience a poor response to ICI treatment, and it can be difficult in some cases to obtain a tumor specimen and evaluate PD‐L1 expression.8 The gene discussed is CD274; the disease is neoplasm.